Cardiorenal end points in a trial of Aliskiren for type 2 diabetes

Abstrakt

This study was undertaken to determin whether use of the direct renin inhibitor aliskiren would reduce cerdiovascular and renal events in patients with type 2 diabetes and chronic kidney disease

Klíčová slova

• Renin inhibitor - Aliskiren, diabetes 2 type
• chronic kidney disease
• cardivasculat disease